Cargando…

Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry

BACKGROUND: Hypoxia inducible factor-1 alpha (HIF-1α), induced by tumor hypoxia, regulates tumor cell metabolism and metastasis by up-regulation of c-Met, carbonic anhydrase 9 (CA9) and glucose transporter 1 (GLUT1). The prognostic significance of hypoxia and metabolic markers is not clearly defined...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Bo Wook, Cho, Hanbyoul, Chung, Joon-Yong, Conway, Catherine, Ylaya, Kris, Kim, Jae-Hoon, Hewitt, Stephen M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750663/ https://www.ncbi.nlm.nih.gov/pubmed/23927384 http://dx.doi.org/10.1186/1479-5876-11-185

Ejemplares similares

Clinical significance of OCT4 and SOX2 protein expression in cervical cancer
por: Kim, Bo Wook, et al.
Publicado: (2015)

Synaptonemal Complex Protein 3 Is a Prognostic Marker in Cervical Cancer
por: Cho, Hanbyoul, et al.
Publicado: (2014)

Apoptosis inhibitor-5 overexpression is associated with tumor progression and poor prognosis in patients with cervical cancer
por: Cho, Hanbyoul, et al.
Publicado: (2014)

HER-2 assessment in formalin-fixed paraffin-embedded breast cancer tissue by well-based reverse phase protein array
por: Perry, Candice, et al.
Publicado: (2014)

Clinical Significance of Tumor Infiltrating Lymphocytes in Association with Hormone Receptor Expression Patterns in Epithelial Ovarian Cancer
por: Han, Gwan Hee, et al.
Publicado: (2021)

Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma
por: Takikita, Mikiko, et al.
Publicado: (2011)

Validation of Potential Protein Markers Predicting Chemoradioresistance in Early Cervical Cancer by Immunohistochemistry
por: Jeong, Soo Young, et al.
Publicado: (2021)

MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer
por: Cho, Hanbyoul, et al.
Publicado: (2014)

Profiling of Phospho-AKT, Phospho-mTOR, Phospho-MAPK and EGFR in Non-small Cell Lung Cancer
por: Kitano, Haruhisa, et al.
Publicado: (2014)

Identification of Prognostic Markers of Gynecologic Cancers Utilizing Patient-Derived Xenograft Mouse Models
por: Shin, Ha-Yeon, et al.
Publicado: (2022)

Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients
por: Hwang, Ilseon, et al.
Publicado: (2020)

DNA Mismatch Repair Protein Immunohistochemistry and MLH1 Promotor Methylation Testing for Practical Molecular Classification and the Prediction of Prognosis in Endometrial Cancer
por: Kim, Jisup, et al.
Publicado: (2018)

Makorin Ring Finger Protein 1 as Adjunctive Marker in Liquid-based Cervical Cytology
por: Lee, Maria, et al.
Publicado: (2016)

ERG Immunohistochemistry as an Endothelial Marker for Assessing Lymphovascular Invasion
por: Kim, Sehun, et al.
Publicado: (2013)

ALDH1A2 Is a Candidate Tumor Suppressor Gene in Ovarian Cancer
por: Choi, Jung-A, et al.
Publicado: (2019)

Ascitic autotaxin as a potential prognostic, diagnostic, and therapeutic target for epithelial ovarian cancer
por: Choi, Jung-A, et al.
Publicado: (2023)

Effects of Automation on Sustainability of Immunohistochemistry Laboratory
por: Đorđević, Marija, et al.
Publicado: (2021)

Prognostic implications of forkhead box protein O1 (FOXO1) and paired box 3 (PAX3) in epithelial ovarian cancer
por: Han, Gwan Hee, et al.
Publicado: (2019)

Prognostic ability of a panel of immunohistochemistry markers – retailoring of an 'old solution'
por: Brennan, Donal J, et al.
Publicado: (2008)

Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification
por: Karnezis, Anthony N, et al.
Publicado: (2017)

Integrating and validating automated digital imaging analysis of estrogen receptor immunohistochemistry in a fully digital workflow for clinical use
por: Shafi, Saba, et al.
Publicado: (2022)

Independent Prognostic Value of Intratumoral Heterogeneity and Immune Response Features by Automated Digital Immunohistochemistry Analysis in Early Hormone Receptor-Positive Breast Carcinoma
por: Zilenaite, Dovile, et al.
Publicado: (2020)

Prognostic significance of natural killer cell-associated markers in gastric cancer: quantitative analysis using multiplex immunohistochemistry
por: Na, Hee Young, et al.
Publicado: (2021)

Genomic Network-Based Analysis Reveals Pancreatic Adenocarcinoma Up-Regulating Factor-Related Prognostic Markers in Cervical Carcinoma
por: Kim, Jihye, et al.
Publicado: (2018)

Automated analysis of images for molecular quantification in immunohistochemistry
por: Guirado, Ramon, et al.
Publicado: (2018)

A ‘Real-Life’ Experience on Automated Digital Image Analysis of FGFR2 Immunohistochemistry in Breast Cancer
por: Braun, Marcin, et al.
Publicado: (2020)

Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer
por: Choi, Chel Hun, et al.
Publicado: (2018)

Cervical Pre-cancers: Biopsy and Immunohistochemistry
por: Kamal, Meherbano
Publicado: (2022)

Erratum: Correction of Acknowledgments. ERG Immunohistochemistry as an Endothelial Marker for Assessing Lymphovascular Invasion
por: Kim, Sehun, et al.
Publicado: (2013)

Diagnostic and prognostic implications of parafibromin immunohistochemistry in parathyroid carcinomaT
por: Pyo, Jung-Soo, et al.
Publicado: (2019)

Nectin-4 as a Predictive Marker for Poor Prognosis of Endometrial Cancer with Mismatch Repair Impairment
por: Chang, Ha Kyun, et al.
Publicado: (2023)

Prognostic value of β-Arrestins in combination with glucocorticoid receptor in epithelial ovarian cancer
por: Ryu, Ji-Won, et al.
Publicado: (2023)

Assessment of a panel of tumor markers for the differential diagnosis of benign and malignant effusions by well-based reverse phase protein array
por: Braunschweig, Till, et al.
Publicado: (2015)

Loss of HES-1 Expression Predicts a Poor Prognosis for Small Intestinal Adenocarcinoma Patients
por: Kim, Jeong Won, et al.
Publicado: (2020)

A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer()()
por: Voorneveld, Philip W., et al.
Publicado: (2015)

An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer
por: Bennedsen, Astrid Louise Bjørn, et al.
Publicado: (2022)

Association between Immunohistochemistry Markers and Tumor Features and Their Diagnostic and Prognostic Values in Intrahepatic Cholangiocarcinoma
por: He, Jiannan, et al.
Publicado: (2022)

Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis
por: Pyo, Jung-Soo, et al.
Publicado: (2019)

Serum Human Epididymis Protein 4 as a Prognostic Marker in Cervical Cancer
por: Hwang, Woo Yeon, et al.
Publicado: (2022)

A simplified two-marker immunohistochemistry strategy for Lynch syndrome screening in endometrial cancer patients
por: Aiob, Ala, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1jrgek2b08c0buib7dp1lq4lus